Pharmaceutical Sales Reps To Be Fired At Pfizer? – When The Best Is Not Good Enough

Market rumors abound that pharmaceutical sales reps at Pfizer may be the next to go. CNBC and Bloomberg are announcing the possibility that 2400 US domestic sales employees (about a third of the sales force) may be let go due to off patent drug expiry, and no doubt the current world financial crisis?

The irony is that we reported about a month ago that Pfizer was ranked number 1 in traditional detailing by physicians.

Pharmaceutical Sales Rep Calls And Sales Force Effectiveness – The Trend

It would not surprising of course to see sales rep layoffs coming in the medical device business as well – judging by the recent news at Cardinal.

Economic Downturn Hits Hospital Supply And Medical Device Business

Bookmark and Share

About Frank Barlin

Frank is the founder and managing partner at Sibaya. He provides recognized leadership in homecare consulting and has advised firms ranging in size from those listed on the NYSE and the LSE to early stage startups. Frank’s international experience is broad-based, having spent his professional life based in Europe, the United States and South Africa. Prior to founding Sibaya in 2002 he was European Vice President for a publicly traded healthcare company. In addition he has held various country general management positions and directorships. Recent home healthcare projects include European business development, acquisition strategy and advice, competitive benchmarking, Asian outsourcing and turnaround management. He works out of the Paris office.

Subscribe

Ways to stay in touch

No comments yet.

Leave a Reply